These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 9653
41. Drug therapies for tardive dyskinesia: Part 1. Howland RH. J Psychosoc Nurs Ment Health Serv; 2011 Jun; 49(6):13-6. PubMed ID: 21598866 [Abstract] [Full Text] [Related]
45. Pimozide in tardive dyskinesia. Calne DB, Claveria LE, Teychenne PF, Haskayne L, Lodge-Patch IC. Trans Am Neurol Assoc; 1974 Sep 04; 99():166-70. PubMed ID: 4618685 [No Abstract] [Full Text] [Related]
46. Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication. Hunter R, Blackwood W, Smith MC, Cumings JN. J Neurol Sci; 1968 Sep 04; 7(2):263-73. PubMed ID: 5707077 [No Abstract] [Full Text] [Related]
47. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses. Salvesen C, Vaksdal K. Behav Neuropsychiatry; 1968 Sep 04; 5(7-12):3-7. PubMed ID: 4154740 [No Abstract] [Full Text] [Related]
48. Meige syndrome and tardive dyskinesia. Glazer WM, Moore DC, Hansen TC, Brenner LM. Am J Psychiatry; 1983 Jun 04; 140(6):798-9. PubMed ID: 6133467 [No Abstract] [Full Text] [Related]
49. Successful treatment of tardive and spontaneous dyskinesias with corticosteroids. Benecke R, Conrad B, Klingelhöfer J. Eur Neurol; 1988 Jun 04; 28(3):146-9. PubMed ID: 2898365 [Abstract] [Full Text] [Related]
50. Effects of zonisamide on tardive dyskinesia: a preliminary open-label trial. Iwata Y, Irie S, Uchida H, Suzuki T, Watanabe K, Iwashita S, Mimura M. J Neurol Sci; 2012 Apr 15; 315(1-2):137-40. PubMed ID: 22285275 [Abstract] [Full Text] [Related]
51. [PERSISTENT DYSKINESIA AFTER PHENOTHIAZINES]. RODOVA A, NAHUNEK K. Cesk Psychiatr; 1964 Aug 15; 60():250-4. PubMed ID: 14195386 [No Abstract] [Full Text] [Related]
52. Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations. Caligiuri MR, Jeste DV, Lacro JP. Drugs Aging; 2000 Nov 15; 17(5):363-84. PubMed ID: 11190417 [Abstract] [Full Text] [Related]
53. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Crane GE. Am J Psychiatry; 1968 Feb 15; 124(8):Suppl:40-8. PubMed ID: 4865731 [No Abstract] [Full Text] [Related]
54. Dyskinesias following therapy with phenothiazine derivatives. FLEGENHEIMER WV. J Mt Sinai Hosp N Y; 1959 Feb 15; 26():440-6. PubMed ID: 13823400 [No Abstract] [Full Text] [Related]
55. Why do schizophrenic patients refuse to take their drugs? Van Putten T. Arch Gen Psychiatry; 1974 Jul 15; 31(1):67-72. PubMed ID: 4151750 [No Abstract] [Full Text] [Related]
56. PHENOTHIAZINE DYSKINESIA AFTER LEUCOTOMY. BEHRMAN S. Lancet; 1964 Aug 22; 2(7356):413. PubMed ID: 14173643 [No Abstract] [Full Text] [Related]
57. Risks vs. benefits of antipsychotic drugs. Baldessarini RJ, Lipinski JF. N Engl J Med; 1973 Aug 23; 289(8):427-8. PubMed ID: 4146359 [No Abstract] [Full Text] [Related]
58. Drug-induced extrapyramidal movement disorders of the face and jaw in dyskinesia. Pfau FR. N C Dent J; 1976 Aug 23; 59(1):20-2. PubMed ID: 25393 [No Abstract] [Full Text] [Related]
59. PERSISTENT ORAL DYSKINESIA IN TREATMENT WITH PHENOTHIAZINE DERIVATIVES. JOYSTON-BECHAL MP. Lancet; 1965 Mar 13; 1(7385):600-1. PubMed ID: 14250095 [No Abstract] [Full Text] [Related]
60. Epidemiology of tardive dyskinesia Part I. Pineau R, Lachance R, Pelchat G, Jus K, Pires P, Pires P, Villenueve. Dis Nerv Syst; 1976 Apr 13; 37(4):210-4. PubMed ID: 3394 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]